Atherton Lane Advisers’s Pfizer PFE Stock Holding History

Atherton Lane Advisers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$27.6M	Buy	901,071 +12,889	+1%	+$405K	1.61%	26
2015 Q3	$26.5M	Buy	888,182 +136,449	+18%	+$4.38M	1.65%	21
2015 Q2	$23.9M	Sell	751,733 -2,027	-0.3%	-$66.1K	1.32%	32
2015 Q1	$24.9M	Buy	753,760 +21,075	+3%	+$670K	1.34%	31
2014 Q4	$21.7M	Sell	732,685 -11,284	-2%	-$324K	1.19%	40
2014 Q3	$20.9M	Sell	743,969 -5,076	-0.7%	-$142K	1.19%	38
2014 Q2	$21.1M	Buy	749,045 +14,352	+2%	+$409K	1.17%	43
2014 Q1	$22.4M	Buy	734,693 +54,095	+8%	+$1.61M	1.39%	29
2013 Q4	$19.8M	Sell	680,598 -29,660	-4%	-$863K	1.25%	41
2013 Q3	$19.4M	Buy	710,258 +51,966	+8%	+$1.41M	1.32%	40
2013 Q2	$17.5M	Buy	+658,292	New	+$18.2M	1.28%	42

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Atherton Lane Advisers's PFE Position: Q4 2015 in Review

Atherton Lane Advisers increased its Pfizer (PFE) stake by 1.5% in Q4 2015, buying an estimated $405K and bringing the position to 901,071 shares worth $27.6M. The position accounts for 1.61% of the portfolio, ranked #26.

Atherton Lane Advisers first reported a position in PFE in Q2 2013 and has held it in 11 quarters since. 1,969 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

Atherton Lane Advisers held 901,071 shares of Pfizer worth $27.6M as of Q4 2015.
Atherton Lane Advisers bought 12,889 Pfizer shares in Q4 2015, an estimated $405K.
Pfizer made up 1.61% of Atherton Lane Advisers's portfolio in Q4 2015, its #26 holding.
Atherton Lane Advisers first reported a position in Pfizer in Q2 2013 and has held it in 11 quarters since.
1,969 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Atherton Lane Advisers's 13F filing for Q4 2015, filed 16 Feb 2016.